Cytomegalovirus (Human herpesvirus 5) IVDs
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
11-11-2017
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Available from:
Biomerieux Australia Pty Ltd
Class:
Class 3
Manufactured by:
Biomerieux SA 376 Chemin de l'Orme, Marcy, L Etoile, 69280 France
Therapeutic area:
CT748 - Cytomegalovirus (Human herpesvirus 5) IVDs
Therapeutic indications:
IVDs that are intended to be used in testing to provide information about infection with or exposure to Cytomegalovirus (CMV).
Authorization status:
A
Authorization date:
2013-01-21
